EVOQUE Adverse Events: FDA MAUDE Data

Edwards Lifesciences LLC · Transcatheter Tricuspid Valve Replacement · First cleared Feb 2024

Total Reports

757

Reports (30d)

0

Active Signals

1

Open Recalls

1

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Conduction Disturbance One Week Post-Procedure

experienced, patient experienced, patient baseline, procedure post, iii

50

reports

2

Complete AV Block Post-Implant

ttvr procedure, tricuspid valve, notification transcatheter, valve replacement, transcatheter tricuspid

29

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Active safety signals

Disproportionate reportinghigh

FDA recalls for this device

Class II

Mar 27, 2026 · Open, Classified

Labeling update to provide warning if functionality of the valve replacement delivery system is compromised.

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 1 active signal detected right now.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.